GAINESVILLE, Fla., March 14, 2011 (GLOBE NEWSWIRE) -- Quick-Med Technologies, Inc. (OTCQB:QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its new Stay Fresh® Antimicrobial Technology will be featured in a podium presentation at the 2011 Techtextil Symposium. The Techtextil Symposium and Exhibition, held March 15-17, is the leading industry meeting in North America dedicated to technical textiles and nonwovens.
Stay Fresh is the newest element of Quick-Med's suite of antimicrobial technologies. It has been designed to rid fabrics of bacteria and fungi responsible for odor and staining in both consumer and institutional applications.
Stay Fresh represents a breakthrough antimicrobial technology. What makes Stay Fresh different from other antimicrobials is its chemistry and extraordinary durability. The active ingredient is hydrogen peroxide – the ingredient that provides the gentle disinfecting and bleaching action in today's generation of color-safe, alternative bleaches. This advance is made possible by Quick-Med's development of the first commercially viable technology for bonding the active ingredient onto the textile.
The symposium presentation, entitled "Peroxide-Based Fabric Functionalization for Antimicrobial and Antifungal Properties", will be delivered by Dr. Bernd Liesenfeld, Principal Scientist and co-inventor of Stay Fresh. Dr. Liesenfeld will describe the chemistry and highly durable efficacy of this revolutionary technology, which is easily applied by textile companies in the manufacturing or finishing process.
"Stay Fresh textile treatment locks the power of hydrogen peroxide into fabrics," according to Dr. Liesenfeld. "Stay Fresh represents a significant advance toward Quick-Med's mission of improving public health by developing and commercializing technologies that interrupt the transfer of pathogens safely, effectively, and affordably through the use of environmentally friendly chemistries."
About Stay Fresh
Stay Fresh is Quick-Med's newest technology platform, offering textile companies a breakthrough in antimicrobial protection to enhance and differentiate their products. Today's leading freshness-enhancing textile technologies are limited in their ability to destroy certain bacteria and unable to maintain efficacy throughout the life of laundered textiles. Stay Fresh is designed to overcome these limitations by providing cost-effective, durable, and sustained antimicrobial protection.
Stay Fresh is the only antimicrobial technology containing hydrogen peroxide approved by EPA for antimicrobial preservation of textiles. The safe, eco-friendly active ingredient in StayFresh is bonded to fibers or fabrics to retain its efficacy for as many as 75 laundering cycles, in hot or cold water. Stay Fresh provides durable, long-lasting antimicrobial efficacy.
Techtextil North America 2011 brings together leading technical textile and nonwovens companies from around the world to showcase the latest products and advanced technologies in textiles, nonwovens and materials. Techtextil North America represents all vertical aspects of the technical textile industry from research and development, through raw materials and production processes, to conversion, further treatment and recycling. The meeting takes place March 15-17 in Las Vegas. For more information, see: .
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the consumer and healthcare markets. The Company is developing advanced antimicrobial technologies for infection prevention and control. Its NIMBUS® technology is the first FDA-cleared, non-leaching antimicrobial available in a wound dressing. Its NimbuDerm™ technology is being developed as a persistent hand sanitizer and its Stay Fresh® technology provides highly durable antimicrobial protection for apparel and other textile applications. For more information, see: .
The Quick-Med Technologies, Inc. logo is available at
© 2011 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and Stay Fresh® are registered trademarks and NimbuDerm™ is a trademark of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.
Note: Antimicrobial information is presented solely to assist in technology evaluation and is not intended to be a public health claim.
CONTACT: Quick-Med Technologies, Inc. J. Ladd Greeno, CEO (888) 835.2211 Ext 102 email@example.com Stonegate Securities, Inc. Casey Stegman (investor/media contact) (214) 987-4121 firstname.lastname@example.org